BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32598338)

  • 1. Mycobacterium abscessus Associated Peritonitis with CAPD Successfully Treated Using a Linezolid and Tedizolid Containing Regimen Suggested Immunomodulatory Effects.
    Seki M; Kamioka Y; Takano K; Imai H; Shoji M; Hariu M; Kabutoya Y; Watanabe Y
    Am J Case Rep; 2020 Jun; 21():e924642. PubMed ID: 32598338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of tedizolid against the Mycobacterium abscessus complex.
    Compain F; Soroka D; Heym B; Gaillard JL; Herrmann JL; Dorchène D; Arthur M; Dubée V
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):186-189. PubMed ID: 29217419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid for treatment of vancomycin-resistant enterococcal peritonitis.
    Bailey EM; Faber MD; Nafziger DA
    Am J Kidney Dis; 2001 Oct; 38(4):E20. PubMed ID: 11576907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of peritoneal dialysis
    Bartolomeo K; Hassanein M; Vachharajani TJ
    J Vasc Access; 2022 Nov; 23(6):966-968. PubMed ID: 33985367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium abscessus - an uncommon, but important cause of peritoneal dialysis-associated peritonitis - case report and literature review.
    Jheeta AS; Rangaiah J; Clark J; Makanjuola D; Somalanka S
    BMC Nephrol; 2020 Nov; 21(1):491. PubMed ID: 33203375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus.
    Kim TS; Choe JH; Kim YJ; Yang CS; Kwon HJ; Jeong J; Kim G; Park DE; Jo EK; Cho YL; Jang J
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674049
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
    Ruth MM; Koeken VACM; Pennings LJ; Svensson EM; Wertheim HFL; Hoefsloot W; van Ingen J
    J Antimicrob Chemother; 2020 Mar; 75(3):609-617. PubMed ID: 31886864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofazimine in
    Pinapala A; Koh LJ; Ng KH; Tambyah PA; Yap HK
    Perit Dial Int; 2021 Jan; 41(1):104-109. PubMed ID: 32148178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged use of tedizolid in a pulmonary non-tuberculous mycobacterial infection after linezolid-induced toxicity.
    Yuste JR; Bertó J; Del Pozo JL; Leiva J
    J Antimicrob Chemother; 2017 Feb; 72(2):625-628. PubMed ID: 27999019
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer.
    Almeida DV; Omansen TF; Li SY; Lee J; Grosset JH; Converse PJ; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559131
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Le Run E; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745387
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure to cure Mycobacterium gordonae peritonitis associated with continuous ambulatory peritoneal dialysis.
    Harro C; Braden GL; Morris AB; Lipkowitz GS; Madden RL
    Clin Infect Dis; 1997 May; 24(5):955-7. PubMed ID: 9142800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen.
    Karaushi H; Seki M; Miyawaki Y; Watanabe N; Kamoshita F; Mitsutake K
    Am J Case Rep; 2022 Oct; 23():e937485. PubMed ID: 36210541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of Mycobacterium fortuitum peritonitis without Tenckhoff catheter removal in CAPD.
    Tang S; Tang AW; Lam WO; Cheng YY; Ho YW
    Perit Dial Int; 2003; 23(3):304-5. PubMed ID: 12938837
    [No Abstract]   [Full Text] [Related]  

  • 15. Peritonitis caused by Mycobacterium kansasii in a patient undergoing continuous ambulatory peritoneal dialysis.
    Giladi M; Lee BE; Berlin OG; Panosian CB
    Am J Kidney Dis; 1992 Jun; 19(6):597-9. PubMed ID: 1595710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex.
    Zhang Z; Lu J; Song Y; Pang Y
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):31-34. PubMed ID: 29089153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child.
    Myojin S; Fukuoka K; Kanemaru A; Baba S; Okamoto Y; Suzuki H; Kamada K; Yoshida A; Kikuchi K; Horikoshi Y
    Int J Infect Dis; 2018 Sep; 74():10-12. PubMed ID: 29966711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritonitis with Mycobacterium fortuitum in a patient on continuous ambulatory peritoneal dialysis.
    Kolmos HJ; Brahm M; Bruun B
    Scand J Infect Dis; 1992; 24(6):801-3. PubMed ID: 1287816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic resistance in
    Jayasingam SD; Zin T; Ngeow YF
    Int J Mycobacteriol; 2017; 6(4):387-390. PubMed ID: 29171453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium abscessus complex bacteremia due to prostatitis after prostate biopsy.
    Chen CH; Lin J; Lin JS; Chen YM
    Indian J Tuberc; 2016 Oct; 63(4):273-275. PubMed ID: 27998503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.